CNTG - CENTOGENE picks entrepreneur and executive Dr. Michael Motz as commercial chief
Centogene (CNTG) appointed entrepreneur and executive with 25+ years experience Dr. Michael Motz as Chief Commercial Officer, Pharmaceuticals, effective June 1.Most recently, he was Entrepreneur in Residence at BB Pureos Bioventures in Zurich, Switzerland."Michael brings a rare blend of deal-making experience and scientific know-how to CENTOGENE's executive leadership team. He will be instrumental in harnessing CENTOGENE's unique Bio/Databank to transform drug discovery and development for genetic hereditary diseases," CEO Andrin Oswald, M.D. commented.
For further details see:
CENTOGENE picks entrepreneur and executive Dr. Michael Motz as commercial chief